I'm confident about the science, but a bit concerned about the cash position of the company and whether it will have enough $ to last another year. Either a capital raising or takeover, if the preliminary results of the phase 11 trials show success in a few months, might be on the cards?
What do you think?
SBP
solbec pharmaceuticals limited
